St. Louis firm with blood test for Alzheimer's disease raises $15M
C2N Diagnostics LLC, a St. Louis-based biotechnology firm that has created a blood test designed to help doctors detect Alzheimer's disease, has secured funding from a Japanese pha…
C2N Diagnostics LLC, a St. Louis-based biotechnology firm that has created a blood test designed to help doctors detect Alzheimer's disease, has secured funding from a Japanese pha…